Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Klepp

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 14, 2004
Knowledge of and attitudes toward complementary and alternative therapies; a national multicentre study of oncology professionals in NorwayT Risberg, A Kolstad, Y Bremnes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1991
Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experienceN Aass, O Klepp, E Cavallin-Stahl, et al.
British Journal of Cancer|November 22, 2012
Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancerM Brydøy, S D Fosså, O Klepp, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1990
A randomized study on hormone-resistant prostatic cancer: estramustine phosphate versus low dose epirubicin with or without medroxyprogesterone acetate. A Norwegian multicenter studyK J Tveter, S Hagen, I Holme, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2006
Components of the metabolic syndrome in long-term survivors of testicular cancerH S Haugnes, N Aass, S D Fosså, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase II trial of anaxirone (TGU) in advanced colorectal cancer: an EORTC Early Clinical Trials Group (ECTG) studyE E Holdener, M Clavel, C Sessa, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1983
Phase II study of amsacrine in solid tumors: a report of the EORTC Early Clinical Trial-GroupR De Jager, P Siegenthaler, F Cavalli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1990
Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. Swedish-Norwegian Testicular Cancer GroupO Klepp, A M Olsson, H Henrikson, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1997
Risk-adapted treatment of clinical stage 1 non-seminoma testis cancerO Klepp, O Dahl, P Flodgren, et al.
Human Reproduction (Oxford, England)|March 10, 2012
Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish populationW Kristiansen, K E Andreassen, R Karlsson, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
European Journal of Cancer (Oxford, England : 1990)|February 14, 2004
Knowledge of and attitudes toward complementary and alternative therapies; a national multicentre study of oncology professionals in NorwayT Risberg, A Kolstad, Y Bremnes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1991
Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experienceN Aass, O Klepp, E Cavallin-Stahl, et al.
British Journal of Cancer|November 22, 2012
Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancerM Brydøy, S D Fosså, O Klepp, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1990
A randomized study on hormone-resistant prostatic cancer: estramustine phosphate versus low dose epirubicin with or without medroxyprogesterone acetate. A Norwegian multicenter studyK J Tveter, S Hagen, I Holme, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2006
Components of the metabolic syndrome in long-term survivors of testicular cancerH S Haugnes, N Aass, S D Fosså, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Phase II trial of anaxirone (TGU) in advanced colorectal cancer: an EORTC Early Clinical Trials Group (ECTG) studyE E Holdener, M Clavel, C Sessa, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1983
Phase II study of amsacrine in solid tumors: a report of the EORTC Early Clinical Trial-GroupR De Jager, P Siegenthaler, F Cavalli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1990
Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. Swedish-Norwegian Testicular Cancer GroupO Klepp, A M Olsson, H Henrikson, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1997
Risk-adapted treatment of clinical stage 1 non-seminoma testis cancerO Klepp, O Dahl, P Flodgren, et al.
Human Reproduction (Oxford, England)|March 10, 2012
Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish populationW Kristiansen, K E Andreassen, R Karlsson, et al.
Pageof 9